Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 6 | 2022 | 1537 | 1.020 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 2376 | 0.770 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 739 | 0.640 |
Why?
|
Wounds, Gunshot | 2 | 2019 | 563 | 0.540 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2916 | 0.530 |
Why?
|
Thromboembolism | 1 | 2021 | 986 | 0.500 |
Why?
|
Cell Adhesion | 1 | 2021 | 3144 | 0.490 |
Why?
|
Aftercare | 1 | 2020 | 866 | 0.480 |
Why?
|
Calcitonin | 1 | 2015 | 336 | 0.470 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 316 | 0.420 |
Why?
|
Protein Precursors | 1 | 2015 | 1154 | 0.380 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 365 | 0.370 |
Why?
|
Computer Simulation | 2 | 2014 | 6196 | 0.370 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2022 | 264 | 0.360 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.320 |
Why?
|
Dyspnea | 2 | 2016 | 1303 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3133 | 0.320 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.310 |
Why?
|
Critical Care | 1 | 2020 | 2647 | 0.300 |
Why?
|
Critical Illness | 1 | 2020 | 2670 | 0.300 |
Why?
|
Vascular Resistance | 2 | 2020 | 936 | 0.290 |
Why?
|
Faculty, Medical | 1 | 2013 | 1181 | 0.260 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3158 | 0.250 |
Why?
|
Endothelial Cells | 4 | 2021 | 3479 | 0.250 |
Why?
|
Internal Medicine | 3 | 2017 | 1009 | 0.240 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5137 | 0.220 |
Why?
|
Education, Medical | 1 | 2014 | 1721 | 0.210 |
Why?
|
Mental Disorders | 1 | 2020 | 6600 | 0.180 |
Why?
|
Ultrasonography | 1 | 2013 | 5985 | 0.180 |
Why?
|
Internship and Residency | 3 | 2017 | 5788 | 0.180 |
Why?
|
Methamphetamine | 1 | 2021 | 154 | 0.180 |
Why?
|
Signal Transduction | 3 | 2021 | 23403 | 0.170 |
Why?
|
Lung | 5 | 2022 | 9856 | 0.170 |
Why?
|
Cough | 1 | 2022 | 555 | 0.160 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 213 | 0.160 |
Why?
|
Collagen Type III | 1 | 2018 | 90 | 0.160 |
Why?
|
Facial Injuries | 1 | 2018 | 183 | 0.150 |
Why?
|
Advisory Committees | 1 | 2020 | 775 | 0.140 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 7659 | 0.130 |
Why?
|
Ventricular Function, Right | 1 | 2019 | 591 | 0.130 |
Why?
|
Fibrosis | 2 | 2021 | 2029 | 0.130 |
Why?
|
Consensus | 2 | 2022 | 2959 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 687 | 0.120 |
Why?
|
Microvessels | 1 | 2019 | 544 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2171 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.120 |
Why?
|
Clinical Competence | 4 | 2020 | 4687 | 0.120 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 223 | 0.110 |
Why?
|
Educational Measurement | 2 | 2017 | 1210 | 0.110 |
Why?
|
Cell Separation | 1 | 2019 | 1751 | 0.110 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2015 | 306 | 0.110 |
Why?
|
Exercise Tolerance | 1 | 2018 | 770 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1148 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.110 |
Why?
|
Paracentesis | 1 | 2012 | 95 | 0.110 |
Why?
|
Electrocardiography | 2 | 2024 | 6442 | 0.110 |
Why?
|
Humans | 30 | 2024 | 744343 | 0.110 |
Why?
|
Lung Diseases | 1 | 2022 | 1886 | 0.100 |
Why?
|
Firearms | 1 | 2018 | 598 | 0.100 |
Why?
|
Gastroenteritis | 1 | 2012 | 245 | 0.090 |
Why?
|
Ascites | 1 | 2012 | 344 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
Problem-Based Learning | 1 | 2014 | 361 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.090 |
Why?
|
Blood Platelets | 1 | 2021 | 2508 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1736 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1221 | 0.090 |
Why?
|
Survivors | 1 | 2020 | 2291 | 0.090 |
Why?
|
Glypicans | 1 | 2009 | 34 | 0.090 |
Why?
|
Male | 17 | 2024 | 350118 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2018 | 2440 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1239 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2531 | 0.080 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1179 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.080 |
Why?
|
Eosinophilia | 1 | 2012 | 541 | 0.080 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2065 | 0.070 |
Why?
|
Middle Aged | 11 | 2024 | 213383 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2012 | 868 | 0.070 |
Why?
|
Postpartum Period | 1 | 2012 | 1086 | 0.070 |
Why?
|
Heart Failure | 2 | 2024 | 10900 | 0.070 |
Why?
|
Autopsy | 2 | 2021 | 1020 | 0.070 |
Why?
|
Coronary Vessel Anomalies | 1 | 2009 | 314 | 0.070 |
Why?
|
Pandemics | 3 | 2020 | 8388 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1713 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 19229 | 0.060 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.060 |
Why?
|
Mortality | 1 | 2015 | 2864 | 0.060 |
Why?
|
Exercise Test | 2 | 2024 | 2074 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20129 | 0.060 |
Why?
|
Prognosis | 3 | 2024 | 29063 | 0.060 |
Why?
|
Female | 11 | 2024 | 380194 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12959 | 0.050 |
Why?
|
Animals | 5 | 2021 | 168757 | 0.050 |
Why?
|
Prone Position | 1 | 2022 | 194 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14722 | 0.040 |
Why?
|
Adult | 7 | 2024 | 214055 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 236 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1912 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 407 | 0.040 |
Why?
|
Edema | 1 | 2022 | 789 | 0.040 |
Why?
|
Advanced Cardiac Life Support | 1 | 2018 | 70 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 438 | 0.040 |
Why?
|
Femoral Vein | 1 | 2018 | 159 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 180 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 3107 | 0.040 |
Why?
|
Plasma Cells | 1 | 2021 | 591 | 0.040 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1869 | 0.040 |
Why?
|
Heart | 1 | 2009 | 4467 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 927 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13284 | 0.030 |
Why?
|
Mice | 2 | 2021 | 81183 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 2020 | 695 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 469 | 0.030 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.030 |
Why?
|
Safety Management | 1 | 2020 | 783 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1850 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2009 | 4584 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3870 | 0.030 |
Why?
|
Face | 1 | 2018 | 994 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 77449 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
Rats | 2 | 2019 | 24260 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15165 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2022 | 2569 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 672 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4161 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1265 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
Chest Pain | 1 | 2016 | 1114 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1470 | 0.020 |
Why?
|
Fistula | 1 | 2009 | 220 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8301 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7149 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3674 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2009 | 783 | 0.020 |
Why?
|
Echocardiography | 1 | 2016 | 5102 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10180 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2009 | 1637 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12072 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2866 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57776 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14557 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13033 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21827 | 0.010 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(122)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_